Cocrystal Pharma, Inc. (COCP)
1.19
-0.02
(-1.65%)
USD |
NASDAQ |
Sep 21, 16:00
1.205
+0.02
(+1.26%)
After-Hours: 20:00
Cocrystal Pharma EPS Diluted (TTM) : -0.7587 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7587 |
| March 31, 2026 | -0.7312 |
| December 31, 2025 | -0.7906 |
| September 30, 2025 | -0.9356 |
| June 30, 2025 | -1.235 |
| March 31, 2025 | -1.558 |
| December 31, 2024 | -1.720 |
| September 30, 2024 | -1.838 |
| June 30, 2024 | -1.763 |
| March 31, 2024 | -1.652 |
| December 31, 2023 | -1.900 |
| September 30, 2023 | -2.014 |
| June 30, 2023 | -10.00 |
| March 31, 2023 | -12.60 |
| December 31, 2022 | -12.48 |
| September 30, 2022 | -12.38 |
| June 30, 2022 | -4.464 |
| March 31, 2022 | -1.984 |
| December 31, 2021 | -1.927 |
| September 30, 2021 | -1.727 |
| June 30, 2021 | -1.799 |
| March 31, 2021 | -2.077 |
| December 31, 2020 | -2.189 |
| September 30, 2020 | -19.95 |
| June 30, 2020 | -20.07 |
| Date | Value |
|---|---|
| March 31, 2020 | -19.84 |
| December 31, 2019 | -18.10 |
| September 30, 2019 | -17.83 |
| June 30, 2019 | -17.90 |
| March 31, 2019 | -17.93 |
| December 31, 2018 | -19.82 |
| September 30, 2018 | 1.531 |
| June 30, 2018 | 1.164 |
| March 31, 2018 | 1.267 |
| December 31, 2017 | 0.702 |
| September 30, 2017 | -35.30 |
| June 30, 2017 | -35.14 |
| March 31, 2017 | -36.29 |
| December 31, 2016 | -38.61 |
| September 30, 2016 | -20.61 |
| June 30, 2016 | -19.91 |
| March 31, 2016 | -19.63 |
| December 31, 2015 | -30.43 |
| September 30, 2015 | -23.23 |
| June 30, 2015 | -26.56 |
| March 31, 2015 | -26.20 |
| December 31, 2014 | -12.21 |
| September 30, 2014 | -5.015 |
| June 30, 2014 | -30.21 |
| March 31, 2014 | -32.81 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.0006 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.1604 |
| Fulcrum Therapeutics, Inc. | -1.213 |
| Definium Therapeutics, Inc. | -3.439 |